Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /UPXI
chevron_leftBack
Upexi, Inc. logo

Upexi, Inc.

UPXI
NASDAQ: UPXI Delayed
1.24USD -5.3%
As of 13 June 2026, Upexi, Inc. has a market cap of $86.5M USD, ranking #26582 globally and #4057 in the United States. It ranks #2379 in the Healthcare sector, and #129 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
26582
Country Rank
4057
Sector Rank
2379
Industry Rank
129
Key Stats
Market Cap
$86.5MUSD
Enterprise Value
$299.06MUSD
Revenue (TTM)
$24.74MUSD
EBITDA (TTM)
-$114.58MUSD
Net Income (TTM)
-$122.93MUSD
PS Ratio
3.5
PB Ratio
1.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Allan Marshall open_in_new
Employees
59
Founded
2018
IPO
24 Jun 2021
Website
upexi.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-5.3% -16% 24% -37% -73% -90%

News

Loading...

UPXI Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
UPXI
Upexi Inc
ISIN: US39959A2050
Shares Out.:
70.262M1 Shares Float: 47.266M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
1.24 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Upexi, Inc.

Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
PE
$29.56B
34K%
-
INDV
$2.07B
1.54B GBP
2K%
-
NDOI
$1.8B
2K%
0.4
$1.76B
2K%
-
$1.33B
1K%
-
$1.02B
1K%
12.1
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$36.75B
108.92B ILS
42K%
24.2
$15.84B
107.34B CNY
18K%
16.0
CIPLA
$11.16B
1.06T INR
13K%
23.4
LUPIN
$11.04B
1.05T INR
13K%
22.7
$9.09B
61.6B CNY
10K%
80.6
$8.74B
7.57B EUR
10K%
-
chevron_leftBack